Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

Overview of attention for article published in Frontiers in oncology, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 3 patents

Citations

dimensions_citation: 127 Dimensions

Readers on

mendeley: 220 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 news story.

miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling

Cancer Cell International, 28 Jan 2022

Abstract Background Despite advances in the development of efficient chemotherapy, the treatment of colorectal cancer (CRC…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.